Gilead Sciences
GILD
#124
Rank
โ‚น16.051 T
Marketcap
โ‚น12,928
Share price
-1.48%
Change (1 day)
38.67%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): โ‚น601.71

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is โ‚น659.52. In 2024 the company made an earnings per share (EPS) of โ‚น36.59 a decrease over its 2023 EPS that were of โ‚น438.07.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น601.711544.63%
2024โ‚น36.59-91.65%
2023โ‚น438.0723.98%
2022โ‚น353.35-25.86%
2021โ‚น476.594850%
2020โ‚น9.63-97.64%
2019โ‚น408.230.9%
2018โ‚น404.6018.71%
2017โ‚น340.83-64.88%
2016โ‚น970.50-18.45%
2015โ‚น1,19055.28%
2014โ‚น766.39296.02%
2013โ‚น193.5217.89%
2012โ‚น164.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น841.14 27.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น126.13-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น197.99-69.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,718 312.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,394 111.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น900.22 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น532.43-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1,638 148.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น342.50-48.07%๐Ÿ‡บ๐Ÿ‡ธ USA